P1446A-05

· Piramal Enterprises Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for P1446A-05, covering 2012-11-21 to 2012-11-22. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies [Phase 1]

See pricing